How social media intelligence can signal blockbuster success: BMS’ Opdivo

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b4/b2/5b/b4b25b14-2ced-9351-68ff-f7e990bd804c/mza_9645698455628093520.jpg/600x600bb.jpg

The Social Intelligence Podcast

CREATION.co

3 episodes

3 days ago

Each week, two AI voices discuss insights from the latest research published by CREATION.co’s analysts. Every episode unpacks a key social listening trend — from product launches to digital opinion leaders — based on real social listening data. These voices are 100% AI-generated. The thinking behind them isn’t. Written by the CREATION.co team — experts in understanding online healthcare conversations. Also available as weekly articles at https://creation.co

How To

Education

RSS

All content for The Social Intelligence Podcast is the property of CREATION.co and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

How To

Education

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/44197848/44197848-1754478621381-c3693b4c76475.jpg

How social media intelligence can signal blockbuster success: BMS’ Opdivo

The Social Intelligence Podcast

6 minutes 9 seconds

2 months ago

How social media intelligence can signal blockbuster success: BMS’ Opdivo

This episode explores how social media intelligence revealed early signals of blockbuster success for Bristol Myers Squibb’s cancer immunotherapy, Opdivo. By analysing healthcare professional conversations online, CREATION.co uncovered insights that shaped understanding of product launches in pharma and the wider implications for future treatments.

In The Social Intelligence Podcast, two AI hosts break down fresh research from CREATION.co’s analysts. This episode is based on an article by Jessica Fernandes, Analyst at CREATION.co.

Read the full article and discover more insights at https://creation.co